Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system

Kantor, E. D., O’Connell, K., Ergas, I. J., Valice, E., Roh, J. M., Bhimani, J., Heon, N., Griggs, J. J., Lee, J., Bowles, E. J., Rivera, D. R., Kolevska, T., Bandera, E. V., & Kushi, L. H. (2023). Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system. Breast Cancer Research and Treatment, 203(3), 565–574. https://doi.org/10.1007/s10549-023-07126-4
Authors:
Elizabeth D Kantor
Kelli O'Connell
Isaac J Ergas
Emily Valice
Janise M Roh
Jenna Bhimani
Narre Heon
Jennifer J Griggs
Jean Lee
Erin Ja Bowles
Donna R Rivera
Tatjana Kolevska
Elisa V Bandera
Lawrence H Kushi
Affiliated Authors:
Narre Heon
Subjects:
Breast Neoplasms (MeSH)
Delivery of Health Care, Integrated (MeSH)
Fumarates (MeSH)
beta-Alanine (MeSH)
Author Keywords:
body surface area
breast cancer
chemotherapy
cyclophosphamide
doxorubicin
paclitaxel
elink
Publication Type:
Article
Unique ID:
10.1007/s10549-023-07126-4
PMID:
37923962
DOI:
10.1007/s10549-023-07126-4
Journal:
Breast Cancer Research and Treatment
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: